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Introduction: Staphylococcus Aureus infective endocarditis (SAIE)
remains a serious disease. Our objective is to study the epidemiological, clin-
ical and echographic characteristics and prognostic factors of left-sided native
valve SAIE, and compare these characterisctics between 2 periods (1990-2000
vs 2001-2010).
Methods: It is a retrospective analysis of 162 left-sided native valve SAIE
in 1254 patients hospitalized for infective endocarditis (IE) at University Hos-
pitals in Amiens and Marseille between 1990 and 2010.
Results: SAIE represents 18% of IE and 22.8% of native valve IE. Complica-
tions include heart failure in 44.7% of the cases, acute renal failure in 23.3%,
sepsis in 28.5%, neurological events in 35.8%, systemic embolic event in 54.9%
and hospital mortality in 25.3%. Factors associated with hospital mortality are
comorbidity index (OR=1.2, p=0.04), heart failure (OR=2.5, p=0.04) and sepsis
(OR=5.3, p=0.001). Overall mortality is 45.4%±7.2% at 48 months. Factors asso-
ciated with overall mortality are comorbidity index (OR=1.1, p=0.017), heart
failure (OR=1.7, p=0.032), sepsis (OR=3, p=0.0001) and delayed surgery
(OR=0.43, p=0.003). The comparison of the 2 periods shows a significant increase
in acute renal failure, bivalvular involvement and valvular insufficiency from 2001
to 2010. There was also a non-significant increase in early surgery (39.1% vs
50%, p=0.2). There was no significant difference in hospital mortality rates
(28.1% vs 23.5%, p=0.58), in overall mortality at 48 months (48.8% vs 42.9%,
p=0.241), and in delayed mortality at 48 months (28.2% vs 23.5%, p=0.225). 
Conclusion: The mortality due to left-sided native valve SAIE remains
elevated. Factors associated with hospital mortality are comorbidity index,
heart failure and sepsis. Factors associated with overall mortality are comor-
bidity index, heart failure, sepsis and delayed surgery. Despite surgical prog-
ress, there is no significant decrease in hospital mortality, overall mortality
and delayed mortality between the 2 periods.
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Introduction: Valvular abnormalities frequently occur in patients with
chronic kidney failure. This study evaluated the prevalence of heart valve cal-
cification (HVC) in hemodialysis patients and factors associated with it.
Materials and Methods: Medical charts of 111 hemodialysis patients
were reviewed retrospectively. Demographic features and laboratory
analysis of the patients were systematically recorded. Echocardiographic
findings were collected, including ejection fraction, aortic valve calcifica-
tion (AVC), mitral valve calcification (MVC), and pulmonary artery pres-
sure.
Results: Valvular abnormalities were found in 17 patients (15,3%);
7 patients (6.3%) had mitral valve calcification, 7 (6.3%) had aortic valve cal-
cification, and 3 (2.7%) had both mitral and aortic valve calcification. There
is a significant difference between patients with and without HVC regarding
serum albumin (41g /l vs 43g/l; p=0.04), CRP rate (23mg/l vs 9,3mg/l;
p=0.0094), and taking calcium carbonate (15 patients vs 2; p=0.04). Regarding
age, sex, the lipid profile, serum calcium, and parathyroid hormone concentra-
tions, there were no significant differences between patients with and without
HVC.
Conclusion: This study failed to show an association between heart valve
calcification in hemodialysis patients and calcium-phosphorus product and
parathyroid hormone levels; however, serum albumin level and CRP rate
could be regarded as risk factors.
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The prevalence of coronary artery disease (CAD) in patients with valvular
heart disease varies widely between developed and in developing countries.
This is likely due, at least in part, to significant differences in etiology: rheu-
matic valvular heart disease is the most important cause of this pathology in
Morocco.
Objective: to estimate the prevalence of coronary artery disease (CAD) in
rheumatic valvular heart disease (RVHD) and to evaluate its interest as a pre-
operative exploration cause of the constraints of cost, appointments, and risks
in our context. Also we studied risk factors prediction of significant coronary
artery disease in patients with RVHD, and discussed other preoperative exams
to explore coronary arteries.
From 01/01/2011 to 31/12/2012, 80 patients underwent coronary angiog-
raphy at the University Hospital cardiac catheterization laboratory of Casa-
blanca prior to planned RVHD surgery. Data analyses were performed using
Epi Info, Version 6.04.
Results: The majority of patients were men (58.75% vs. 41.25%). The
prevalence of Coronary Artery Disease found was 20%. These patients were
all over the age of 55 years. The rate of hypertension was high 62.5% while
only 37.5% were current smokers and 75% of the patients had more than one
cardiovascular risk factor. Chest pain was found in 12.5%. 38% had mitral
valvular disease, 38% had aortic valvular disease and 30% both. The analysis
showed that in our population, age and systemic arterial hypertension (SAH)
were the most related to CAD in rheumatic valvular disease.
Conclusion: the prevalence of CAD among RVHD patients is low.
Gender, age and SAH were identified as being strongly associated with the
presence of CAD in our population.
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